As a pioneer in the women's health movement, Searle looks on the current flurry of interest in this issue with satisfaction. To borrow a popular consumer product slogan, we've "been there and done that," and are renewing our leadership focus. Searle was a co-developer of the first oral contraceptive Enovid, which was introduced in 1960. "The Pill," as it came to be known, provided women around the world with reproductive freedom and helped launch the women's movement. It had a dramatic impact outside the sphere of medicine and irreversibly changed the world's social and economic landscape. Today, approximately 80 percent of American women born since 1945 have taken the Pill -- a trend made possible by Searle's innovative spirit and accomplishments in women's health.
Searle now offers one of the most comprehensive product lines of oral contraceptives and other women's healthcare products available worldwide, including treatment for common and potentially dangerous vaginal infections and therapy that manages the debilitating symptoms of endometriosis.
For more info on these stories, contact Pam Rasmussen (parasm@searle.monsanto.com) at (847) 470-6163 or Jack Domeischel (jrdome@searle.monsanto.com) at (847) 470-6720.
For press releases older than six months, search Searle's press archive.
The sites listed are not sponsored by Searle and their listing here does not reflect Searle participation or endorsement. The listing is not all-inclusive but is provided as a guide to some of the sites that have related information.
WEB SITES:
RELATED DISCUSSION GROUPS:
(Note: Information offered by discussion group participants may not be medically accurate and does not necessarily reflect the beliefs or knowledge of Searle or its employees. Please discuss any medical information gleaned from Internet discussion groups with your physician.)
If you know of a link that should be on this list, please contact webmaster@www.SearlehealthNet.com.
 |
 |
 |
